In his career, which has spanned well over two decades, Nikin Khanna has received numerous accolades which show that he has been an influential figure in his field. He currently serves as CEO of MergerTech an investment bank based in Portland, Oregon. Khanna was born in India in 1971 and eventually studied at Purdue University and went on to earn a masters degree in industrial engineering from there as well. He went on to help to start tech company Saber Corp with his brother in 1999.
A serial entrepreneur, Khanna turned his attention towards the cannabis industry. He served as the CEO of Cura Cannabis Solutions, or CuraCann. The medical community, as well as government officials, are now recognizing the medical benefits of cannabis. The oil can help with anxiety, chronic pain, and other medical issues. The company sells oil and cannabis vape cartridges and will soon expand to Nevada, California, and Oregon. He even has Canada in his sights and hopes to be the largest supplier of cannabis worldwide. He envisions the company offering edible products as well. There are various tests that the products have to go through in order to be sold. In Oregon, for example, they are tested for potency and pesticide residue. The company’s goal is to provide the best quality product and the results are available on the company’s website.
Khanna also sits on the advisory boards of several companies including Vendscreen, TiE Oregon and Freewire Broadbank. With Mergertech, he is able to act as an investor helping start-up small, mobile companies in Portland
Khanna is not all work and no play. He is a self-taught DJ. While he’s not getting paid for it, its one of his quirky habits. Nitin Khanna is a well-rounded individual who is sure to be a force in business for many years to come.
Read more here https://www.facebook.com/nitinkhanna
Eric Lefkofsy, an American billionaire, was born in Southfield, Michigan. He attended the University of Michigan and graduated with honors in 1991. He is the CEO of Groupon and Co-founder of Tempus. In 2015, Eric Lefkofsky co-founded Tempus a company focused on collecting and analyzing large volumes of molecular and clinical data. They have built data pipelines to collect, cleanse, and analyze data. Lefkofsky has cited a family member illness as the impetus for starting the company. The function of Tempus is to improve care.
Tempus allows partnering doctors to use their analytics system to find out more about their patients. According to Lefkofsky, Tempus is hiring five to ten people a week. Tempus collaborates with the majority of the National Cancer Institute’s comprehensive cancer centers in the country, and they are constructing the biggest library on earth where clinical and molecular data can be readily accessible and useful. Community hospitals and local providers work with Tempus as well. Tempus has signed numerous partnerships; in fact, they have signed with more community partnerships than academic medical centers. Lefkofsky is one of the well-establish philanthropists in the Chicago area and the nation. The overwhelming success of Groupon, together with the gains from different ventures gave Lefkofsky opportunities additionally to concentrate on philanthropic pursuits. With his positive contributions through charity, He has been in a position to earn a beneficial effect on the community for many decades. In 2006, he established the Lefkofsky Foundation, and it was created to enhance the quality of human life in the communities.
Eric Lefkofsky moved over into the area of tech just as the online bubble was beginning to grow. He continues to spearhead the usage of technology to be able to benefit patients. Success is something that Eric Lefkofsky is used to seeing as co-founder of numerous innovative businesses. Eric Lefkofsky is notorious for showing people how to get the best bargains on things such as restaurants and travel accommodations with a small company called Groupon. Over the span of his career, Eric Lefkofsky has founded and co-founded a variety of startup companies like Groupon and Lightbank.